Employing nanotechnology to reduce cancer metastasis

Michael King is Professor of Biomedical Engineering at Cornell. The King lab is currently testing novel cancer therapies in mouse models of metastatic breast and prostate cancer through the use of whole body luminescence imaging. This work will uncover new therapeutic targets designed to prevent metastasis.

Image courtesy of interviewee. November 28, 2016

Faculti

Popular in Engineering

Control of a Wheelchair-Mounted Robotic Arm System

Spatiotemporal evaporating droplet dynamics on fomites enhances long term bacterial pathogenesis

Suitability of excavated London clay as a supplementary cementitious material

Polyfluorene-Wrapped Carbon Nanotubes Decorated with Photocleavable Side-Chains

A Trusted and Privacy-Preserving Internet of Mobile Energy

Water Security: Why We Need Global Solutions

Decision-Making Principles for Better Software Design Decisions

Employing nanotechnology to reduce cancer metastasis

Next in Biomedical Engineering